EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders
EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders
Recruiting · NCT07450391 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders | EBV-Positive Lymphoma; Epstein-Barr Virus-Associated Lymphoproliferative Disorders | Recruiting | Phase 1 / Phase 2 | 2026-03-04 | NCT07450391 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Daihong Liu | 13 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese PLA General Hospital | Beijing | China | 87 |